ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global DNA & RNA Oligonucleotides Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-39R10149
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global DNA RNA Oligonucleotides Market Insights Forecast to 2028
BUY CHAPTERS

Global DNA & RNA Oligonucleotides Market Research Report 2025

Code: QYRE-Auto-39R10149
Report
July 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Eurofins Scientific
Natera
BGI
Illumina Inc
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Genotypic Technology
Dna Link

DNA & RNA Oligonucleotides Market Size

The global market for DNA & RNA Oligonucleotides was valued at US$ 1309 million in the year 2024 and is projected to reach a revised size of US$ 1541 million by 2031, growing at a CAGR of 2.4% during the forecast period.

DNA & RNA Oligonucleotides Market

DNA & RNA Oligonucleotides Market

An oligonucleotide is a short chain of DNA or RNA molecules. It is used in molecular biology and medicine as a probe to screen for diseases, viral infections, and to identify genes in molecular biology experiments. It is also used as a primer in a type of DNA sequencing. Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences.
North American market for DNA & RNA Oligonucleotides is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for DNA & RNA Oligonucleotides is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for DNA & RNA Oligonucleotides in Hospitals and Clinics is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of DNA & RNA Oligonucleotides include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Genotypic Technology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for DNA & RNA Oligonucleotides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA & RNA Oligonucleotides.
The DNA & RNA Oligonucleotides market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DNA & RNA Oligonucleotides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA & RNA Oligonucleotides companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of DNA & RNA Oligonucleotides Market Report

Report Metric Details
Report Name DNA & RNA Oligonucleotides Market
Accounted market size in year US$ 1309 million
Forecasted market size in 2031 US$ 1541 million
CAGR 2.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals and Clinics
  • Biopharma Companies
  • Academic & Research Organizations
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Genotypic Technology, Dna Link
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of DNA & RNA Oligonucleotides company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is DNA & RNA Oligonucleotides Market growing?

Ans: The DNA & RNA Oligonucleotides Market witnessing a CAGR of 2.4% during the forecast period 2025-2031.

What is the DNA & RNA Oligonucleotides Market size in 2031?

Ans: The DNA & RNA Oligonucleotides Market size in 2031 will be US$ 1541 million.

Who are the main players in the DNA & RNA Oligonucleotides Market report?

Ans: The main players in the DNA & RNA Oligonucleotides Market are Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences, Macrogen, Genotypic Technology, Dna Link

What are the Application segmentation covered in the DNA & RNA Oligonucleotides Market report?

Ans: The Applications covered in the DNA & RNA Oligonucleotides Market report are Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations, Others

What are the Type segmentation covered in the DNA & RNA Oligonucleotides Market report?

Ans: The Types covered in the DNA & RNA Oligonucleotides Market report are DNA Oligonucleotides, RNA Oligonucleotides

Recommended Reports

Oligonucleotide Synthesis

Therapeutics & Drugs

Nucleic Acid Analysis

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 DNA Oligonucleotides
1.2.3 RNA Oligonucleotides
1.3 Market by Application
1.3.1 Global DNA & RNA Oligonucleotides Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic & Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global DNA & RNA Oligonucleotides Market Perspective (2020-2031)
2.2 Global DNA & RNA Oligonucleotides Growth Trends by Region
2.2.1 Global DNA & RNA Oligonucleotides Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 DNA & RNA Oligonucleotides Historic Market Size by Region (2020-2025)
2.2.3 DNA & RNA Oligonucleotides Forecasted Market Size by Region (2026-2031)
2.3 DNA & RNA Oligonucleotides Market Dynamics
2.3.1 DNA & RNA Oligonucleotides Industry Trends
2.3.2 DNA & RNA Oligonucleotides Market Drivers
2.3.3 DNA & RNA Oligonucleotides Market Challenges
2.3.4 DNA & RNA Oligonucleotides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA & RNA Oligonucleotides Players by Revenue
3.1.1 Global Top DNA & RNA Oligonucleotides Players by Revenue (2020-2025)
3.1.2 Global DNA & RNA Oligonucleotides Revenue Market Share by Players (2020-2025)
3.2 Global DNA & RNA Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by DNA & RNA Oligonucleotides Revenue
3.4 Global DNA & RNA Oligonucleotides Market Concentration Ratio
3.4.1 Global DNA & RNA Oligonucleotides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA & RNA Oligonucleotides Revenue in 2024
3.5 Global Key Players of DNA & RNA Oligonucleotides Head office and Area Served
3.6 Global Key Players of DNA & RNA Oligonucleotides, Product and Application
3.7 Global Key Players of DNA & RNA Oligonucleotides, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA & RNA Oligonucleotides Breakdown Data by Type
4.1 Global DNA & RNA Oligonucleotides Historic Market Size by Type (2020-2025)
4.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2026-2031)
5 DNA & RNA Oligonucleotides Breakdown Data by Application
5.1 Global DNA & RNA Oligonucleotides Historic Market Size by Application (2020-2025)
5.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America DNA & RNA Oligonucleotides Market Size (2020-2031)
6.2 North America DNA & RNA Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America DNA & RNA Oligonucleotides Market Size by Country (2020-2025)
6.4 North America DNA & RNA Oligonucleotides Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe DNA & RNA Oligonucleotides Market Size (2020-2031)
7.2 Europe DNA & RNA Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe DNA & RNA Oligonucleotides Market Size by Country (2020-2025)
7.4 Europe DNA & RNA Oligonucleotides Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size (2020-2031)
8.2 Asia-Pacific DNA & RNA Oligonucleotides Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2020-2025)
8.4 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America DNA & RNA Oligonucleotides Market Size (2020-2031)
9.2 Latin America DNA & RNA Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America DNA & RNA Oligonucleotides Market Size by Country (2020-2025)
9.4 Latin America DNA & RNA Oligonucleotides Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size (2020-2031)
10.2 Middle East & Africa DNA & RNA Oligonucleotides Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2020-2025)
10.4 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Company Details
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific DNA & RNA Oligonucleotides Introduction
11.1.4 Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2020-2025)
11.1.5 Eurofins Scientific Recent Development
11.2 Natera
11.2.1 Natera Company Details
11.2.2 Natera Business Overview
11.2.3 Natera DNA & RNA Oligonucleotides Introduction
11.2.4 Natera Revenue in DNA & RNA Oligonucleotides Business (2020-2025)
11.2.5 Natera Recent Development
11.3 BGI
11.3.1 BGI Company Details
11.3.2 BGI Business Overview
11.3.3 BGI DNA & RNA Oligonucleotides Introduction
11.3.4 BGI Revenue in DNA & RNA Oligonucleotides Business (2020-2025)
11.3.5 BGI Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina DNA & RNA Oligonucleotides Introduction
11.4.4 Illumina Revenue in DNA & RNA Oligonucleotides Business (2020-2025)
11.4.5 Illumina Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche DNA & RNA Oligonucleotides Introduction
11.5.4 Roche Revenue in DNA & RNA Oligonucleotides Business (2020-2025)
11.5.5 Roche Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Details
11.6.2 LabCorp Business Overview
11.6.3 LabCorp DNA & RNA Oligonucleotides Introduction
11.6.4 LabCorp Revenue in DNA & RNA Oligonucleotides Business (2020-2025)
11.6.5 LabCorp Recent Development
11.7 Berry Genomics
11.7.1 Berry Genomics Company Details
11.7.2 Berry Genomics Business Overview
11.7.3 Berry Genomics DNA & RNA Oligonucleotides Introduction
11.7.4 Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2020-2025)
11.7.5 Berry Genomics Recent Development
11.8 Brooks Life Sciences
11.8.1 Brooks Life Sciences Company Details
11.8.2 Brooks Life Sciences Business Overview
11.8.3 Brooks Life Sciences DNA & RNA Oligonucleotides Introduction
11.8.4 Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2020-2025)
11.8.5 Brooks Life Sciences Recent Development
11.9 Macrogen
11.9.1 Macrogen Company Details
11.9.2 Macrogen Business Overview
11.9.3 Macrogen DNA & RNA Oligonucleotides Introduction
11.9.4 Macrogen Revenue in DNA & RNA Oligonucleotides Business (2020-2025)
11.9.5 Macrogen Recent Development
11.10 Genotypic Technology
11.10.1 Genotypic Technology Company Details
11.10.2 Genotypic Technology Business Overview
11.10.3 Genotypic Technology DNA & RNA Oligonucleotides Introduction
11.10.4 Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2020-2025)
11.10.5 Genotypic Technology Recent Development
11.11 Dna Link
11.11.1 Dna Link Company Details
11.11.2 Dna Link Business Overview
11.11.3 Dna Link DNA & RNA Oligonucleotides Introduction
11.11.4 Dna Link Revenue in DNA & RNA Oligonucleotides Business (2020-2025)
11.11.5 Dna Link Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Eurofins Scientific
Natera
BGI
Illumina Inc
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Genotypic Technology
Dna Link
List of Tables
 Table 1. Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of DNA Oligonucleotides
 Table 3. Key Players of RNA Oligonucleotides
 Table 4. Global DNA & RNA Oligonucleotides Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global DNA & RNA Oligonucleotides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global DNA & RNA Oligonucleotides Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global DNA & RNA Oligonucleotides Market Share by Region (2020-2025)
 Table 8. Global DNA & RNA Oligonucleotides Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global DNA & RNA Oligonucleotides Market Share by Region (2026-2031)
 Table 10. DNA & RNA Oligonucleotides Market Trends
 Table 11. DNA & RNA Oligonucleotides Market Drivers
 Table 12. DNA & RNA Oligonucleotides Market Challenges
 Table 13. DNA & RNA Oligonucleotides Market Restraints
 Table 14. Global DNA & RNA Oligonucleotides Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global DNA & RNA Oligonucleotides Market Share by Players (2020-2025)
 Table 16. Global Top DNA & RNA Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA & RNA Oligonucleotides as of 2024)
 Table 17. Ranking of Global Top DNA & RNA Oligonucleotides Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by DNA & RNA Oligonucleotides Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of DNA & RNA Oligonucleotides, Headquarters and Area Served
 Table 20. Global Key Players of DNA & RNA Oligonucleotides, Product and Application
 Table 21. Global Key Players of DNA & RNA Oligonucleotides, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global DNA & RNA Oligonucleotides Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global DNA & RNA Oligonucleotides Revenue Market Share by Type (2020-2025)
 Table 25. Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global DNA & RNA Oligonucleotides Revenue Market Share by Type (2026-2031)
 Table 27. Global DNA & RNA Oligonucleotides Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global DNA & RNA Oligonucleotides Revenue Market Share by Application (2020-2025)
 Table 29. Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global DNA & RNA Oligonucleotides Revenue Market Share by Application (2026-2031)
 Table 31. North America DNA & RNA Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America DNA & RNA Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America DNA & RNA Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe DNA & RNA Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe DNA & RNA Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe DNA & RNA Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific DNA & RNA Oligonucleotides Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America DNA & RNA Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America DNA & RNA Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America DNA & RNA Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa DNA & RNA Oligonucleotides Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Eurofins Scientific Company Details
 Table 47. Eurofins Scientific Business Overview
 Table 48. Eurofins Scientific DNA & RNA Oligonucleotides Product
 Table 49. Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 50. Eurofins Scientific Recent Development
 Table 51. Natera Company Details
 Table 52. Natera Business Overview
 Table 53. Natera DNA & RNA Oligonucleotides Product
 Table 54. Natera Revenue in DNA & RNA Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 55. Natera Recent Development
 Table 56. BGI Company Details
 Table 57. BGI Business Overview
 Table 58. BGI DNA & RNA Oligonucleotides Product
 Table 59. BGI Revenue in DNA & RNA Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 60. BGI Recent Development
 Table 61. Illumina Company Details
 Table 62. Illumina Business Overview
 Table 63. Illumina DNA & RNA Oligonucleotides Product
 Table 64. Illumina Revenue in DNA & RNA Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 65. Illumina Recent Development
 Table 66. Roche Company Details
 Table 67. Roche Business Overview
 Table 68. Roche DNA & RNA Oligonucleotides Product
 Table 69. Roche Revenue in DNA & RNA Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 70. Roche Recent Development
 Table 71. LabCorp Company Details
 Table 72. LabCorp Business Overview
 Table 73. LabCorp DNA & RNA Oligonucleotides Product
 Table 74. LabCorp Revenue in DNA & RNA Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 75. LabCorp Recent Development
 Table 76. Berry Genomics Company Details
 Table 77. Berry Genomics Business Overview
 Table 78. Berry Genomics DNA & RNA Oligonucleotides Product
 Table 79. Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 80. Berry Genomics Recent Development
 Table 81. Brooks Life Sciences Company Details
 Table 82. Brooks Life Sciences Business Overview
 Table 83. Brooks Life Sciences DNA & RNA Oligonucleotides Product
 Table 84. Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 85. Brooks Life Sciences Recent Development
 Table 86. Macrogen Company Details
 Table 87. Macrogen Business Overview
 Table 88. Macrogen DNA & RNA Oligonucleotides Product
 Table 89. Macrogen Revenue in DNA & RNA Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 90. Macrogen Recent Development
 Table 91. Genotypic Technology Company Details
 Table 92. Genotypic Technology Business Overview
 Table 93. Genotypic Technology DNA & RNA Oligonucleotides Product
 Table 94. Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 95. Genotypic Technology Recent Development
 Table 96. Dna Link Company Details
 Table 97. Dna Link Business Overview
 Table 98. Dna Link DNA & RNA Oligonucleotides Product
 Table 99. Dna Link Revenue in DNA & RNA Oligonucleotides Business (2020-2025) & (US$ Million)
 Table 100. Dna Link Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. DNA & RNA Oligonucleotides Picture
 Figure 2. Global DNA & RNA Oligonucleotides Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global DNA & RNA Oligonucleotides Market Share by Type: 2024 VS 2031
 Figure 4. DNA Oligonucleotides Features
 Figure 5. RNA Oligonucleotides Features
 Figure 6. Global DNA & RNA Oligonucleotides Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global DNA & RNA Oligonucleotides Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals and Clinics Case Studies
 Figure 9. Biopharma Companies Case Studies
 Figure 10. Academic & Research Organizations Case Studies
 Figure 11. Others Case Studies
 Figure 12. DNA & RNA Oligonucleotides Report Years Considered
 Figure 13. Global DNA & RNA Oligonucleotides Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global DNA & RNA Oligonucleotides Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global DNA & RNA Oligonucleotides Market Share by Region: 2024 VS 2031
 Figure 16. Global DNA & RNA Oligonucleotides Market Share by Players in 2024
 Figure 17. Global Top DNA & RNA Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA & RNA Oligonucleotides as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by DNA & RNA Oligonucleotides Revenue in 2024
 Figure 19. North America DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America DNA & RNA Oligonucleotides Market Share by Country (2020-2031)
 Figure 21. United States DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe DNA & RNA Oligonucleotides Market Share by Country (2020-2031)
 Figure 25. Germany DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific DNA & RNA Oligonucleotides Market Share by Region (2020-2031)
 Figure 33. China DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America DNA & RNA Oligonucleotides Market Share by Country (2020-2031)
 Figure 41. Mexico DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa DNA & RNA Oligonucleotides Market Share by Country (2020-2031)
 Figure 45. Turkey DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE DNA & RNA Oligonucleotides Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Eurofins Scientific Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2020-2025)
 Figure 49. Natera Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2020-2025)
 Figure 50. BGI Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2020-2025)
 Figure 51. Illumina Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2020-2025)
 Figure 52. Roche Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2020-2025)
 Figure 53. LabCorp Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2020-2025)
 Figure 54. Berry Genomics Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2020-2025)
 Figure 55. Brooks Life Sciences Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2020-2025)
 Figure 56. Macrogen Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2020-2025)
 Figure 57. Genotypic Technology Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2020-2025)
 Figure 58. Dna Link Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Oligonucleotides Market Insights Forecast to 2030
Global Oligonucleotide Market Research Report 2025
Global Oligo Synthesis Market Research Report 2025
Global Oligonucleotide Oligo Drugs Market Research Report 2024
Global DNA Oligonucleotide Synthesis Market Insights Forecast to 2030
Oligonucleotide Synthesis Linkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oligonucleotide Therapeutics Market Research Report 2024
Global Oligonucleotide Synthesizer Market Research Report 2024
Global DNA and RNA Oligonucleotide Synthesizers Market Research Report 2024
Global Phosphoramidites for Oligonucleotides Market Research Report 2024
Global Oligo Synthesizer Market Insights Forecast to 2030
Oligonucleotide Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nucleic Acids for Molecular Diagnosis Market Research Report 2024
Global Oligonucleotide Synthesis Services Market Insights Forecast to 2030
Oligonucleotide Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
DNA And RNA Synthesis Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antisense Oligonucleotide Service Market Research Report 2025
Global Antisense Oligonucleotides ASOs Drugs Market Research Report 2024
Global Oligonucleotide Therapy based Drug Market Research Report 2024
Global Nucleotide Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions